127 related articles for article (PubMed ID: 38574272)
1. Toward More Selective Antibiotic Inhibitors: A Structural View of the Complexed Binding Pocket of
Kirschner H; Heister N; Zouatom M; Zhou T; Hofmann E; Scherkenbeck J; Stoll R
J Med Chem; 2024 Apr; 67(8):6384-6396. PubMed ID: 38574272
[TBL] [Abstract][Full Text] [Related]
2. Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.
Boularot A; Giglione C; Petit S; Duroc Y; Alves de Sousa R; Larue V; Cresteil T; Dardel F; Artaud I; Meinnel T
J Med Chem; 2007 Jan; 50(1):10-20. PubMed ID: 17201406
[TBL] [Abstract][Full Text] [Related]
3. Ligand-induced changes in the structure and dynamics of Escherichia coli peptide deformylase.
Amero CD; Byerly DW; McElroy CA; Simmons A; Foster MP
Biochemistry; 2009 Aug; 48(32):7595-607. PubMed ID: 19627112
[TBL] [Abstract][Full Text] [Related]
4. The crystal structure of mitochondrial (Type 1A) peptide deformylase provides clear guidelines for the design of inhibitors specific for the bacterial forms.
Fieulaine S; Juillan-Binard C; Serero A; Dardel F; Giglione C; Meinnel T; Ferrer JL
J Biol Chem; 2005 Dec; 280(51):42315-24. PubMed ID: 16192279
[TBL] [Abstract][Full Text] [Related]
5. Peptide deformylase inhibitors with retro-amide scaffold: synthesis and structure-activity relationships.
Lee SK; Choi KH; Lee SJ; Suh SW; Kim BM; Lee BJ
Bioorg Med Chem Lett; 2010 Aug; 20(15):4317-9. PubMed ID: 20615695
[TBL] [Abstract][Full Text] [Related]
6. Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents.
Jain R; Chen D; White RJ; Patel DV; Yuan Z
Curr Med Chem; 2005; 12(14):1607-21. PubMed ID: 16022661
[TBL] [Abstract][Full Text] [Related]
7. Structures of Staphylococcus aureus peptide deformylase in complex with two classes of new inhibitors.
Lee SJ; Lee SJ; Lee SK; Yoon HJ; Lee HH; Kim KK; Lee BJ; Lee BI; Suh SW
Acta Crystallogr D Biol Crystallogr; 2012 Jul; 68(Pt 7):784-93. PubMed ID: 22751663
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship analysis and therapeutic potential of peptide deformylase inhibitors.
Boularot A; Giglione C; Artaud I; Meinnel T
Curr Opin Investig Drugs; 2004 Aug; 5(8):809-22. PubMed ID: 15600237
[TBL] [Abstract][Full Text] [Related]
9. Structural variation and inhibitor binding in polypeptide deformylase from four different bacterial species.
Smith KJ; Petit CM; Aubart K; Smyth M; McManus E; Jones J; Fosberry A; Lewis C; Lonetto M; Christensen SB
Protein Sci; 2003 Feb; 12(2):349-60. PubMed ID: 12538898
[TBL] [Abstract][Full Text] [Related]
10. Peptide deformylase inhibitors with non-peptide scaffold: synthesis and structure-activity relationships.
Lee SK; Choi KH; Lee SJ; Lee JS; Park JY; Kim BM; Lee BJ
Bioorg Med Chem Lett; 2011 Jan; 21(1):133-6. PubMed ID: 21146987
[TBL] [Abstract][Full Text] [Related]
11. Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs.
Gao J; Liang L; Zhu Y; Qiu S; Wang T; Zhang L
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428963
[TBL] [Abstract][Full Text] [Related]
12. 2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitors.
Apfel C; Banner DW; Bur D; Dietz M; Hubschwerlen C; Locher H; Marlin F; Masciadri R; Pirson W; Stalder H
J Med Chem; 2001 Jun; 44(12):1847-52. PubMed ID: 11384231
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship analysis of the peptide deformylase inhibitor 5-bromo-1H-indole-3-acetohydroxamic acid.
Petit S; Duroc Y; Larue V; Giglione C; Léon C; Soulama C; Denis A; Dardel F; Meinnel T; Artaud I
ChemMedChem; 2009 Feb; 4(2):261-75. PubMed ID: 19053131
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor.
Clements JM; Beckett RP; Brown A; Catlin G; Lobell M; Palan S; Thomas W; Whittaker M; Wood S; Salama S; Baker PJ; Rodgers HF; Barynin V; Rice DW; Hunter MG
Antimicrob Agents Chemother; 2001 Feb; 45(2):563-70. PubMed ID: 11158755
[TBL] [Abstract][Full Text] [Related]
15. Structure of the Ni(II) complex of Escherichia coli peptide deformylase and suggestions on deformylase activities depending on different metal(II) centres.
Yen NT; Bogdanović X; Palm GJ; Kühl O; Hinrichs W
J Biol Inorg Chem; 2010 Feb; 15(2):195-201. PubMed ID: 20112455
[TBL] [Abstract][Full Text] [Related]
16. Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.
Hu X; Nguyen KT; Jiang VC; Lofland D; Moser HE; Pei D
J Med Chem; 2004 Sep; 47(20):4941-9. PubMed ID: 15369398
[TBL] [Abstract][Full Text] [Related]
17. Docking studies of nickel-peptide deformylase (PDF) inhibitors: exploring the new binding pockets.
Wang Q; Zhang D; Wang J; Cai Z; Xu W
Biophys Chem; 2006 Jun; 122(1):43-9. PubMed ID: 16545516
[TBL] [Abstract][Full Text] [Related]
18. A peptide deformylase-ribosome complex reveals mechanism of nascent chain processing.
Bingel-Erlenmeyer R; Kohler R; Kramer G; Sandikci A; Antolić S; Maier T; Schaffitzel C; Wiedmann B; Bukau B; Ban N
Nature; 2008 Mar; 452(7183):108-11. PubMed ID: 18288106
[TBL] [Abstract][Full Text] [Related]
19. Peptide deformylase inhibitors.
Aubart K; Zalacain M
Prog Med Chem; 2006; 44():109-43. PubMed ID: 16697896
[No Abstract] [Full Text] [Related]
20. Novel approaches to antimicrobial therapy: peptide deformylase.
Waller AS; Clements JM
Curr Opin Drug Discov Devel; 2002 Sep; 5(5):785-92. PubMed ID: 12630299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]